Jacob Westman,Johan Malm,Johan Wannberg,Natalia Nekhotiaeva,Ulrika Bäckman
申请号：
BRPI0820210
公开号：
BRPI0820210A2
申请日:
2008.11.14
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
A compound of formula (I) as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition having a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema or psoriasis.
